Status:

UNKNOWN

The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)

Lead Sponsor:

Leiden University Medical Center

Collaborating Sponsors:

Dutch Donor Feces Bank

Vedanta Biosciences

Conditions:

NAFLD

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

Nonalcoholic fatty liver disease (NAFLD) is a disease of alarmingly increasing prevalence, linked to metabolic, cardiovascular and malignant morbidity and without any officially approved treatment. It...

Detailed Description

Nonalcoholic fatty liver disease (NAFLD) is a disease of alarmingly increasing prevalence, linked to metabolic, cardiovascular and malignant morbidity and without any officially approved treatment. It...

Eligibility Criteria

Inclusion

  • Obese (BMI \> 27 kg/m2)
  • Males and postmenopausal females
  • Aged 18 to 70 years
  • Hepatic steatosis defined as increased hyperechogenicity of the liver on abdominal ultrasound and/or histological signs of steatosis
  • Written informed consent

Exclusion

  • Exclusion criteria for MRI (claustrophobia, pacemaker, metal implants, etc)
  • Any other liver disease than NAFLD/NASH
  • Present excessive alcohol use defined as \> 2 units/day
  • Recent use (\< 3 months) of antibiotics
  • use of possible drugs interfering microbiota or recent (\< 3 months) changes in dosages
  • use of GLP-1 RA or SU-derivatives
  • Recent (\< 3 months) weight change (\>5%)
  • Cardiovascular co-morbidity defined as heart failure, coronary insufficiency and hypertension in past history
  • Previous use of glucocorticosteroids, hormonal substitution, pagitaxel, theofyllin, amiodarone, myelosuppresive agents.
  • A psychiatric, addictive or any other disorder that compromises the subjects ability to understand the study content and to give written informed consent for participation in the study

Key Trial Info

Start Date :

December 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04465032

Start Date

December 10 2019

End Date

December 31 2021

Last Update

July 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Leiden University Medical Center

Leiden, Netherlands, 2333 ZA